N-Methyl-D-aspartate Receptor Ion-Channel Blockers
J ournal of Medicinal Chemistry, 1997, Vol. 40, No. 26 4289
M.; Ball, R. G.; Amato, J . S.; Larsen, R. D.; Wong, E. H. F.;
Kemp, J . A.; Tricklebank, M. D.; Singh, L.; Oles, R.; Priestley,
T.; Marshall, G. R.; Knight, A. R.; Middlemiss, D. N.; Woodruff,
G. N.; Iversen, L. L. Synthesis and Pharmacological Evaluation
Refer en ces
(1) (a) Watkins, J . C.; Collingridge, G. L. The NMDA Receptor: New
Vistas. Oxford University Press: London, 1989; p 227-233. (b)
Greenamyre, J . T. The role of Glutamate in Neurotransmission
and Neurologic Disease. Arch. Neurol. 1986, 43, 1058-1063. (c)
Wieloch, T. Hypoglycemia-Induced Neuronal Damage Prevented
by an N-Methyl Aspartate Antagonist. Science 1985, 230, 681-
683. (d) Iversen, L. L. MK-801 (Dizocilpine Maleate)-NMDA
Receptor Antagonist. Neurotransmission 1994, vol. X, number
1.
(2) Honey, C. R.; Miljkovic, Z.; Macdonald, J . F. Ketamine and
Phencyclidine Cause a Voltage-Dependent Block of Responses
to L-Aspartic Acid. Neurosci. Lett. 1985, 61, 135-139.
(3) Benavides, J .; Rivy, J .-P.; Carter, C.; Scatton, B. Differential
Modulation of [3H]-TCP Binding to the NMDA Receptor by
L-Glutamate and Glycine. Eur. J . Pharmacol. 1988, 149, 62-
72.
D-
of a series of Dibenzo[a,d]cycloalkenimines as N-methyl-
aspartate Antagonist. J . Med. Chem. 1990, 33, 789-808.
(8) Gee, K. R.; Barmetter, P.; Rhodes, M.; McBurney, R. N.; Reddy,
N. L.; Hu, L.-Y.; Cotter, R. E.; Fischer, J . B.; Weber, E.; Keana,
J . F. W. 10,5-(Iminomethano)-10,11-dihydro-5H-dibenzo[a,d]-
cycloheptene and Derivatives. Potent PCP Receptor Ligands. J .
Med. Chem. 1993, 36, 1938-1946.
(9) (a) Zukin, S. R.; Zukin, R. Specific [3H]phecyclidine binding in
rat central nervous system. Proc. Natl. Acad. Sci. U.S.A. 1979,
76, 5372-5376. (b) Keana, J . F. W.; McBurney, R. N.; Scherz,
M. W.; Fischer, J . B.; Hamilton, P. N.; Smith, S. M.; Server, A.
C.; Finkbeiner, S.; Stevens, C. F.; J ahr, C.; and Weber, E.
Synthesis and Characterization of A Series of Diarylguanidines
That Are Non-competitive N-Methyl-D-Aspartate Receptor An-
tagonists with Neuroprotective Properties. Proc. Natl. Acad. Sci.
U.S.A. 1989, 86, 5631-5635.
(4) (a) Itzhak, Y. Pharmacological Specificity of Some Psychotomi-
metic and Antipsychotic Agents for the Sigma and PCP Binding
Sites. Life Sci. 1988, 42, 745-752. (b) Kumar, V.; Carabateas,
P. M.; Dority, J . A., J r.; Earley, W. G.; Mallamo, J . P.; Subra-
manyam, C.; Aimone, L. D.; Ault, B.; Hudkin, D. L. D.; Miller,
M. S. Novel NMDA Antagonist: Replacement of the Pyridinium
Ring of 6, 11-Ethanobenzo[b]quinolizinium Cations with Het-
eroisoquinolinium Cations. J . Med. Chem. 1995, 38 (10), 1826-
30.
(5) (a) Bigge, C. F.; J ohnson, G.; Hays, S. J .; Malone, T. C.; Ortwine,
D. F.; Boxer, P. A.; Marcoux, F. W.; Coughenour, L. L. Mutiple
Sigma and PCP receptor Ligands: Mechanisms for Neuromodu-
lation and Neuroprotection?; Kamenka, J .-M., Domino, E. F.,
Eds.; NPP Books: Ann Arbor, MI, 1992; pp 1-20. (b) Bigge, C.
F.; Malone, T. C.; Hays, S. J .; J ohnson, G.; Novak, P. M.;
Lescosky, L. J .; Retz, D. M.; Ortwine, D. F.; Probert, A. W. J r.;
Coughenour, L. L.; Boxer, P. A.; Robichaud, L. J .; Shillis J . L.
Synthesis and Pharmacological Evaluation of 4R-Phenanthre-
namine Derivatives Acting at the Phecyclidine Binding Site of
the N-Methyl-D-aspartate Receptor Complex. J . Med. Chem.
1993, 36, 1977-1995. (c) Hays, S. J .; Novak, P. M.; Ortwine, D.
F.; Bigge, C. F.; Colbry, N. L.; J ohnson, G.; Lescosky, L. J .;
Malone, T. C.; Michael, A.; Reily, M. D.; Coughenour, L. L.;
Brahce, L. J .; Shillis, J . L.; Probert, A. W., J r. Synthesis and
Pharmacological Evaluation of Hexahydrofluorenamine as Non-
competitive Antagonosts at N-Methyl-D-aspartate Receptor. J .
Med. Chem. 1993, 36, 654-670. (d) Kozikowski, A. P. and Pang,
Y. P. Structural Determinants of Affinity for the Phencyclidine
Binding Site of the N-methyl-D-aspartate Receptor Complex:
Discovery of a Rigid Phencyclidine Analogues of High Affinity
Binding. Mol. Pharmacol. 1990, 37, 352-357.
(6) (a) Reddy, N. L.; Hu, L.-Y.; Cotter, R. E.; Fischer, J . B.; Wong,
W. J .; McBurney, R. N.; Holmes, L. D.; Wong, S. T.; Prasad, R.;
and Keana, J . F. W. Synthesis and Structure-Activity Studies
of N,N′-Diarylguanidine Derivatives. N-(1-Naphthyl)-N′-(3-
ethylphenyl)-N′-methyl-guanidine: A New, Selective Noncom-
petitive NMDA Receptor Antagonist. J . Med. Chem. 1994, 37,
260-267. (b) Hu, L.-Y.; Durant, D. J .; Reddy, N. L.; Cotter, R.
E.; Fischer, J . B.; McBurney, R. N.; Weber, E.; Prasad, K. J . R.;
Lu, Y.; Keana, J . F. W. Med. Chem. Res. 1994, 4, 146-152. (c)
Keana, J . F. W.; McBurney, R. N.; Scherz, M. W.; Fischer, J . B.;
Hamilton, P. N.; Smith, S. M.; Server, A. C.; Finkbeiner, S.;
Stevens, C. F.; J ahr, C.; Weber, E. Synthesis and Characteriza-
tion of A Series of Diarylguanidines That Are Noncompetitive
N-Methyl-D-aspartate Receptor Antagonists with Neuroprotec-
tive Properties. Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 5631-
5635. (d) CERESTAT is a registered trademark of Cambridge
NeuroScience, Inc. CERESTAT is being jointly developed by
Cambridge NeuroScience, Inc. and Boehringer Ingelheim, GMBH.
(7) (a) Wong, E. H. F.; Kemp, J . A.; Priestley, T.; Knight, A. R.;
Woodruff, G. N.; Iversen, L. L. The anticonvulsant MK-801 is a
potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci.
U.S.A. 1986, 83, 7104-7108. (b) Thomspson, W. J .; Anderson,
P. S.; Britcher, S. F.; Lyle, T. A.; Thies, J . E.; Magill, C. A.; Varga,
S. L.; Schwering, J . E.; Lyle, P. A.; Christy, M. E.; Evans, B. E.;
Colton, C. D.; Holloway, M. K.; Springer, J . P.; Hirshfield, J .
(10) (a) Rao, T. S.; Cler, J . A.; Mick, S. J .; Ragan, D. M.; Lanthorn,
T. H.; Contreras, P. C.; Iyengar, S.; Wood, P. L. Opipramol, A
Potent Sigma Ligand, Is An Anti-ischemic Agent: Neurochemi-
cal Evidence for An Interaction with The N-Methyl-D-Aspartate
Receptor Complex In Vivo By Cerebellar cGMP Measurement.
Neuropharmacology 1990, 29 (12), 1199-1204. (b) Pontecorov,
M. J .; Karbon, E. W.; Goode, S.; Clissold, D. B.; Borosky, S. A.;
Patch, R. J .; and Ferkany, J . W. Possible Cerebroprotective and
in vivo NMDA Antagonist Activities of Sigma Agent. Brain Res.
Bull. 1991, 26, 461-465. (c) Sharp, F. R.; Wang, B. S.; Koisti-
naho, J .; Graham, S. H.; Sagar, S. M.; Noble, L.; Berger, P.; and
Longo, F. M. Haloperidol prevents induction of the hsp70 heat
shock gene in neurons injured by phencyclidine (PCP), MK801,
and ketamine. J . Neurosci. Res. 1992, 33, 605-616.
(11) (a) Weber, E.; Sonders, M. S.; Quarum, M.; Mclean, S.; Pou, S.;
Keana, J . F. W. 1,3-Di(2-[5-3H]-tolyl)guanidine: A Selective
Ligand That Labels Sigma Type Receptors For Psychomimetic
Opiates And Antipsychotic Drugs. Proc. Natl. Acad. Sci. U.S.A.
1986, 83, 8784-8788. (b) Keana, J . F. W.; Scherz, M. W.;
Quarum, M.; Sonders, M. S.; Weber, E. Syntheses And Char-
acterization Of A Radiolabeled Derivative Of The Phencyclidine/
N-methyl-D-aspartate Receptor Ligand (+)MK-801 with High
Specific Radioactivity. Life Sci. 1988, 3, 965-967.
(12) Cheng, Y.; Prvsoff, W. H. Relationship Between The Inhibition
Constant (Ki) And The Concentration Of Inhibitor Which Causes
50 Per Cent Inhibition (IC50) Of An Enzyme Reaction. Biochem.
Pharmacol. 1973, 22, 3099-3108.
(13) (a) A Textbook Of Drug Design And Development; Krogsgaard,
P., Bundgaard, H., Eds.; Harwood Academic Publicher: New
York, 1991; p 80. (b) Inami, Y.; Tomita, T.; Terada, Q. Quantita-
tive Structure-Activity Relaionship Analysis Of Phencyclidine
Derivatives. Chem. Pharm. Bull. 1991, 39, 1426-1428.
(14) Merchant, J . R.; Deshpande, A. R.; J adhav, R. G. Rearangement
Of The Oximes Of 4-Trichloromethyl-4-ethyl- And 4-Trichloro-
methyl-3,4-dimethyl-2,5-cyclohexadi-enone. Indian J . Chem.
Sect. B 1978, 16B (5), 385-388.
(15) Truedsson, L. A. Liquid Chromatography Study Of Brominated
Aniline And Investigation Of Product Formation In The Bromi-
nation Reaction. II Anilines With Alkyl Groups In the meta-
Position. J . Chromatog. 1982, 234 (1), 36-47.
(16) 2-Bromo-5-methylthiobenzoic acid was prepared by the method
described in the following Kuenzle, F.; Schmutz, J . Seven-
membered Heterocycles. XII. Dibenzo[b,f]-1,4-oxazepin-11(10H)-
ones And Dibenzo[b,e]-1,4-oxazepin-11(5H)-ones. Helv. Chim.
Acta 1969, 52 (3), 622-628.
(17) Scherz, W. M; Fialeix, M.; Fischer, J . B.; Reddy, N. L.; Server,
A. C.; Sonders, M. S.; Tester, B. C.; Weber, E.; Wong, S. T.;
Keana, J . F. K. Synthesis And Structure-Activity Relationships
Of N,N′-Di-o-tolylguanidine Analogues, High-Affinity Ligands
For The Haloperidol-Sensitive σ Receptor. J . Med. Chem. 1990,
33, 2421-2425.
J M970459C